Clearance Summary
QUANTIMETRIX TOTAL CREATINE KINASE CONTROL received FDA 510(k) clearance under submission number K874302, sponsored by Quantimetrix Medical Industries. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1988-02-02.
- Submission: K874302
- Applicant / Sponsor: Quantimetrix Medical Industries
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.1660
- Decision date: 1988-02-02
Classification & Regulation
This clearance is catalogued under FDA product code JJT and 21 CFR 862.1660, within the Clinical Chemistry review panel as a Class I device.